CALCITONIN FOR PREVENTION OF POSTMENOPAUSAL BONE LOSS

The Lancet

Volumn 331, Issue 8591, 1988, Pages 900-902

  Macintyre, I ^a   Whitehead, M I ^c   Banks, L M ^a   Stevenson, J C ^b   Wimalawansa, S J ^a   Healy, M J R ^d  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b Department of Diagnostic Radiology Royal Postgraduate Medical School United Kingdon ^*

^c KING'S COLLEGE LONDON   (United Kingdom)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN;

CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; OSTEOPOROSIS; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ADULT; CALCITONIN; CLINICAL TRIALS; COMPARATIVE STUDY; ESTRADIOL; FEMALE; FOLLOW-UP STUDIES; HUMAN; INJECTIONS, SUBCUTANEOUS; MIDDLE AGE; OSTEOPOROSIS; PATIENT COMPLIANCE; PILOT PROJECTS; PROGESTERONE; RANDOM ALLOCATION; SELF ADMINISTRATION; SUPPORT, NON-U.S. GOV'T;

EID: 0023889776     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(88)91712-6     Document Type: Article

References (33)

1. Calatonin—a hormone from parathyroid which lowers the calcium level of blood
2. Further evidence for calcitonin. a rapid acting hormone which lowers plasma calcium
3. Thyroid origin of calcitonin
4. Thyroid hypocalcemic principle and recurrent laryngeal nerve injury as factors affecting the response to parathyroidectomy in rats
5. Calcitonin production and the mitochondrionrich cells of the dog thyroid
6. Abundant calcitonin receptors in isolated rat osteoclasts. Biochemical and autoradiographic characterization
7. Calcitonin alters behaviour of isolated osteoclasts
8. Human calcitonin
9. Calcitonin: a general survey
10. Menopausal changes in bone remodelling
11. Bone formation and resorption as the determinants of trabecular bone volume in postmenopausal osteoporosis
12. Epidemiology of age related fractures
13. Osteoporosis
14. Conference Report Consensus Development Conference Aalborg Denmark prophylaxis and treatment of osteoporosis
15. Estrogen replacement therapy. A 10-year prospective study in relationship to osteoporosis
16. Prevention of spinal osteoporosis in oophorectomised women
17. Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy
18. Precise measurenment of vertebral mineral content using computed tomography
19. Modified method of spinal computed tomography for trabecular bone mineral measurements
20. Activities of bone and liver alkaline phosphatases in serum in health and disease
21. Meaasurement of the fasting urinary hydroxyproline: creatinine ratio in normal adults and its variation with age and sex
22. Hip fracture and the use of estrogen in postmenopausal osteoporosis
23. Relative deficiency of plasma-calcitonin in normal women
24. Regulation of calcium-regulating hormones by exogenous sex steroids in early postmenopause
25. The effect of oestrogens on human calcitonin secretion after calcium infusion in elderly female subjects
26. Effects of estradiol and progesterone on calcitonin secrenon
27. 125I-17-estradiol binding
28. Evidence of estrogen receptors in human bone cells
29. Long-term calcitonin therapy in postmenopausal osteoporosis
30. Intra-nasal calcitonin in the treatment of postmenopausal osteoporosis
31. Comparative effects on bone mineral content of calcium and calcium plus salmon calcitonin given in two different regimens in postmenopausal osteoporosis
32. Effect of salmon calcitonin on skeletal mass in osteoporosis
33. 1-year controlled randomised trial of prevention of early postmenopausal bone loss by intranasal calcitonin